{"pageContent": "Importance: The benefit of prostate-specific antigen screening may be greatest in high-risk populations, including men of African descent in the Caribbean. However, organized screening may not be sustainable in low- and middle-income countries.", "metaData": {"source": "[Erectile dysfunction in patients treated for bladder and prostate cancer]\nhttps://pubmed.ncbi.nlm.nih.gov/20141064/"}}